|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yano T, Muto M, Minashi K, Iwasaki J,
Kojima T, Fuse N, Doi T, Kaneko K and Ohtsu A: Photodynamic therapy
as salvage treatment for local failure after chemoradiotherapy in
patients with esophageal squamous cell carcinoma: A phase II study.
Int J Cancer. 131:1228–1234. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang L, Wu YD, Li P, Tu J, Niu YL, Xu CM
and Zhang ST: Effects of cyclooxygenase-2 on human esophageal
squamous cell carcinoma. World J Gastroenterol. 17:4572–4580. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lagergren J, Smyth E, Cunningham D and
Lagergren P: Oesophageal cancer. Lancet. 390:2383–2396. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rustgi AK and El-Serag HB: Esophageal
carcinoma. N Engl J Med. 371:2499–2509. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Takaesu G, Kishida S, Hiyama A, Yamaguchi
K, Shibuya H, Irie K, Ninomiya-Tsuji J and Matsumoto K: TAB2, a
novel adaptor protein, mediates activation of TAK1 MAPKKK by
linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol
Cell. 5:649–658. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Besse A, Lamothe B, Campos AD, Webster WK,
Maddineni U, Lin SC, Wu H and Darnay BG: TAK1-dependent signaling
requires functional interaction with TAB2/TAB3. J Biol Chem.
282:3918–3928. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu Y, Liu JP, Zhu Y and Lu NH: The
importance of toll-like receptors in NF-κB signaling pathway
activation by helicobacter pylori infection and the regulators of
this response. Helicobacter. 21:428–440. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen J, Gu J, Feng J, Liu Y, Xue Q, Ni T,
Wang Z, Jia L, Mao G and Ji L: TAB3 overexpression promotes cell
proliferation in non-small cell lung cancer and mediates
chemoresistance to CDDP in A549 cells via the NF-κB pathway. Tumour
Biol. 37:3851–3861. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tao T, He Z, Shao Z and Lu H: TAB3
O-GlcNAcylation promotes metastasis of triple negative breast
cancer. Oncotarget. 7:22807–22818. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen Y, Wang X, Duan C, Chen J, Su M, Jin
Y, Deng Y, Wang D, Chen C, Zhou L, et al: Loss of TAB3 expression
by shRNA exhibits suppressive bioactivity and increased chemical
sensitivity of ovarian cancer cell lines via the NF-κB pathway.
Cell Prolif. 49:657–668. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM classification of malignant tumours. John Wiley & Sons;
2011
|
|
15
|
Roh YS, Song J and Seki E: TAK1 regulates
hepatic cell survival and carcinogenesis. J Gastroenterol.
49:185–194. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Luo C, Yuan R, Chen L, Zhou W, Shen W, Qiu
Y and Shao J, Yan J and Shao J: TAB3 upregulates Survivin
expression to promote colorectal cancer invasion and metastasis by
binding to the TAK1-TRAF6 complex. Oncotarget. 8:106565–106576.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Malumbres M and Carnero A: Cell cycle
deregulation: A common motif in cancer. Prog Cell Cycle Res.
5:5–18. 2003.PubMed/NCBI
|
|
18
|
Boonstra J and Moes MJ: Signal
transduction and actin in the regulation of G1-phase progression.
Crit Rev Eukaryot Gene Expr. 15:255–276. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hulleman E and Boonstra J: Regulation of
G1 phase progression by growth factors and the extracellular
matrix. Cell Mol Life Sci. 58:80–93. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tashima Y, Hamada H, Okamoto M and Hanai
T: Prediction of key factor controlling G1/S phase in the mammalian
cell cycle using system analysis. J Biosci Bioeng. 106:368–374.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gan J, Ke X, Jiang J, Dong H, Yao Z, Lin
Y, Lin W, Wu X, Yan S, Zhuang Y, et al: Growth hormone-releasing
hormone receptor antagonists inhibit human gastric cancer through
downregulation of PAK1-STAT3/NF-kappaB signaling. Proc Natl Acad
Sci USA. 113:14745–14750. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jung JU, Ravi S, Lee DW, McFadden K,
Kamradt ML, Toussaint LG and Sitcheran R: NIK/MAP3K14 regulates
mitochondrial dynamics and trafficking to promote cell invasion.
Curr Biol. 26:3288–3302. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gan X, Chen B, Shen Z, Liu Y, Li H, Xie X,
Xu X, Li H, Huang Z and Chen J: High GPX1 expression promotes
esophageal squamous cell carcinoma invasion, migration,
proliferation and cisplatin-resistance but can be reduced by
vitamin D. Int J Clin Exp Med. 7:2530–2540. 2014.PubMed/NCBI
|
|
24
|
Han Y, Guo XH, Zheng QF, Zhu YL, Fan YY
and Zhang XY: Down-regulation of platelet-derived growth factor-D
expression blockades NF-κB pathway to inhibit cell proliferation
and invasion as well as induce apoptosis in esophageal squamous
cell carcinoma. Mol Biol Rep. 40:2473–2483. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gao S, Sun Y, Zhang X, Hu L, Liu Y, Chua
CY, Phillips LM, Ren H, Fleming JB, Wang H, et al: IGFBP2 activates
the NF-κB pathway to drive epithelial-mesenchymal transition and
invasive character in pancreatic ductal adenocarcinoma. Cancer Res.
76:6543–6554. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pires BR, Mencalha AL, Ferreira GM, de
Souza WF, Morgado-Díaz JA, Maia AM, Corrêa S and Abdelhay ES:
NF-kappaB is involved in the regulation of EMT genes in breast
cancer cells. PLoS One. 12:e01696222017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shin WS, Hong Y, Lee HW and Lee ST:
Catalytically defective receptor protein tyrosine kinase PTK7
enhances invasive phenotype by inducing MMP-9 through activation of
AP-1 and NF-κB in esophageal squamous cell carcinoma cells.
Oncotarget. 7:73242–73256. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou J, Zheng S, Liu T, Liu Q, Chen Y, Tan
D, Ma R and Lu X: MCP2 activates NF-κB signaling pathway promoting
the migration and invasion of ESCC cells. Cell Biol Int.
42:365–372. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jin G, Klika A, Callahan M, Faga B, Danzig
J, Jiang Z, Li X, Stark GR, Harrington J and Sherf B:
Identification of a human NF-kappaB-activating protein, TAB3. Proc
Natl Acad Sci USA. 101:2028–2033. 2004. View Article : Google Scholar : PubMed/NCBI
|
